Have a personal or library account? Click to login

Pressurized Perfusion System for Obtaining Completely Acellular Pulmonary Valve Scaffolds for Tissue Engineering

Open Access
|Mar 2020

References

  1. 1. Coffey S, Cairns BJ, Iung B. The modern epidemiology of heart valve disease. Heart. 2016 Jan;102(1):75-85.10.1136/heartjnl-2014-30702026541169
  2. 2. Cribier A. Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey. Arch Cardiovasc Dis. 2012 Mar;105(3):146-52.10.1016/j.acvd.2012.01.00522520797
  3. 3. Cullen MW, Cabalka AK, Alli OO, Pislaru SV, Sorajja P, Nkomo VT, et al. Transvenous, antegrade Melody valve-in-valve implantation for bioprosthetic mitral and tricuspid valve dysfunction: a case series in children and adults. JACC Cardiovasc Interv. 2013 Jun;6(6):598-605.10.1016/j.jcin.2013.02.01023683739
  4. 4. Schillinger W, Senges J. (TRAMI (Transcatheter Mitral Valve Interventions) register. The German mitral register). Herz. 2013 Aug;38(5):453-9.10.1007/s00059-013-3858-323797374
  5. 5. Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012 Oct;27(10):1361-7.10.1007/s11606-012-2077-6344567622618581
  6. 6. Friedewald VE, Bonow RO, Borer JS, Carabello BA, Kleine PP, Akins CW, et al. The Editor’s Roundtable: cardiac valve surgery. Am J Cardiol. 2007 May 1;99(9):1269-78.10.1016/j.amjcard.2007.02.04017478156
  7. 7. Mikos AG, Herring SW, Ochareon P, Elisseeff J, Lu HH, Kandel R, et al. Engineering complex tissues. Tissue Eng. 2006 Dec;12(12):3307-39.10.1089/ten.2006.12.3307282121017518671
  8. 8. Yacoub MH, Takkenberg JJ. Will heart valve tissue engineering change the world? Nat Clin Pract Cardiovasc Med. 2005 Feb;2(2):60-1.10.1038/ncpcardio011216265355
  9. 9. van Geldorp MW, Eric Jamieson WR, Kappetein AP, Ye J, Fradet GJ, Eijkemans MJ, et al. Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk. J Thorac Cardiovasc Surg. 2009 Apr;137(4):881-6, 6e1-5.10.1016/j.jtcvs.2008.09.028
  10. 10. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017 Sep 21;38(36):2739-91.
  11. 11. Hoffmann G, Lutter G, Cremer J. Durability of bioprosthetic cardiac valves. Dtsch Arztebl Int. 2008 Feb;105(8):143-8.10.3238/arztebl.2008.0143269673819633780
  12. 12. Langer R, Vacanti JP. Tissue engineering. Science. 1993 May 14;260(5110):920-6.10.1126/science.84935298493529
  13. 13. Sodian R, Hoerstrup SP, Sperling JS, Daebritz S, Martin DP, Moran AM, et al. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation. 2000 Nov 7;102(19 Suppl 3):III22-9.10.1161/01.CIR.102.suppl_3.III-22
  14. 14. Shinoka T, Ma PX, Shum-Tim D, Breuer CK, Cusick RA, Zund G, et al. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation. 1996 Nov 1;94(9 Suppl):II164-8.
  15. 15. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP, et al. Functional living trileaflet heart valves grown in vitro. Circulation. 2000 Nov 7;102(19 Suppl 3):Iii44-9.10.1161/01.CIR.102.suppl_3.III-44
  16. 16. Shinoka T, Breuer CK, Tanel RE, Zund G, Miura T, Ma PX, et al. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg. 1995 Dec;60(6 Suppl):S513-6.10.1016/S0003-4975(21)01185-1
  17. 17. Badylak SF, Taylor D, Uygun K. Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng. 2011 Aug 15;13:27-53.10.1146/annurev-bioeng-071910-12474321417722
  18. 18. Dahl SL, Koh J, Prabhakar V, Niklason LE. Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant. 2003;12(6):659-66.10.3727/00000000310874713628866947
  19. 19. Sung HJ, Meredith C, Johnson C, Galis ZS. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials. 2004 Nov;25(26):5735-42.10.1016/j.biomaterials.2004.01.06615147819
  20. 20. Schaner PJ, Martin ND, Tulenko TN, Shapiro IM, Tarola NA, Leichter RF, et al. Decellularized vein as a potential scaffold for vascular tissue engineering. J Vasc Surg. 2004 Jul;40(1):146-53.10.1016/j.jvs.2004.03.03315218475
  21. 21. Kajbafzadeh AM, Javan-Farazmand N, Monajemzadeh M, Baghayee A. Determining the optimal decellularization and sterilization protocol for preparing a tissue scaffold of a human-sized liver tissue. Tissue Eng Part C Methods. 2013 Aug;19(8):642-51.10.1089/ten.tec.2012.033423270591
  22. 22. Nakayama KH, Lee CC, Batchelder CA, Tarantal AF. Tissue specificity of decellularized rhesus monkey kidney and lung scaffolds. PLoS One. 2013;8(5):e64134.10.1371/journal.pone.0064134366147723717553
  23. 23. DeQuach JA, Yuan SH, Goldstein LS, Christman KL. Decellularized porcine brain matrix for cell culture and tissue engineering scaffolds. Tissue Eng Part A. 2011 Nov;17(21-22):2583-92.10.1089/ten.tea.2010.0724320419721883047
  24. 24. Sierad LN, Shaw EL, Bina A, Brazile B, Rierson N, Patnaik SS, et al. Functional Heart Valve Scaffolds Obtained by Complete Decellularization of Porcine Aortic Roots in a Novel Differential Pressure Gradient Perfusion System. Tissue Eng Part C Methods. 2015 Dec;21(12):1284-96.10.1089/ten.tec.2015.0170
  25. 25. Kerrison P, Steinke M. DAPI staining protocol.
  26. 26. Inno-train Diagnostic GMBH. Manual DNA Extraction with magnetic beads. 2019 (cited 2019); Available from: https://www.inno-train.de/en/products/dna-isolation/bexs-12-ready-dna-kits/.
  27. 27. Waterbolk TW, Hoendermis ES, den Hamer IJ, Ebels T. Pulmonary valve replacement with a mechanical prosthesis. Promising results of 28 procedures in patients with congenital heart disease. Eur J Cardiothorac Surg. 2006 Jul;30(1):28-32.10.1016/j.ejcts.2006.02.06916730181
  28. 28. Freling HG, van Slooten YJ, van Melle JP, Ebels T, Hoendermis ES, Berger RM, et al. Pulmonary valve replacement: twenty-six years of experience with mechanical valvar prostheses. Ann Thorac Surg. 2015 Mar;99(3):905-10.10.1016/j.athoracsur.2014.10.03425617228
  29. 29. Schwedler G, Lindinger A, Lange PE, Sax U, Olchvary J, Peters B, et al. Frequency and spectrum of congenital heart defects among live births in Germany : a study of the Competence Network for Congenital Heart Defects. Clin Res Cardiol. 2011 Dec;100(12):1111-7.10.1007/s00392-011-0355-721909849
  30. 30. Shebani SO, McGuirk S, Baghai M, Stickley J, De Giovanni JV, Bu’lock FA, et al. Right ventricular outflow tract reconstruction using Contegra valved conduit: natural history and conduit performance under pressure. Eur J Cardiothorac Surg. 2006 Mar;29(3):397-405.10.1016/j.ejcts.2005.11.04016439155
  31. 31. Boethig D, Horke A, Hazekamp M, Meyns B, Rega F, Van Puyvelde J, et al. A European study on decellularized homografts for pulmonary valve replacement: initial results from the prospective ESPOIR Trial and ESPOIR Registry datadagger. Eur J Cardiothorac Surg. 2019 Sep 1;56(3):503-910.1093/ejcts/ezz054673576330879050
  32. 32. Arise Hannover. Welcome to Arise. 2019; Available from: http://arise-clinicaltrial.eu/home.html.
DOI: https://doi.org/10.2478/arsm-2019-0030 | Journal eISSN: 1841-4036 | Journal ISSN: 1223-9666
Language: English
Page range: 149 - 156
Published on: Mar 3, 2020
Published by: Ovidius University of Constanta
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Movileanu Ionela, Brinzaniuc Klara, Harpa Marius, Nistor Dan, Cotoi Ovidiu, Terezia Preda, Hussein Hussam Al, Moldovan Oana, Man Adrian, Harceaga Lucian, Sierad Leslie, Simionescu Dan, published by Ovidius University of Constanta
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.